What we choose to call cancer may shape patients’ behavior in ways that influence their health outcomes. Relabeling low-grade ...

Please provide your email address to receive an email when new articles are posted on . A deep-learning algorithm detected prostate lesions on multiparametric MRI and tracked lesions throughout the ...

A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, "Deep learning-assisted lesion segmentation in PET/CT imaging: A feasibility study for salvage radiation ...

Prostate cancer is the second most common cancer in men, and almost 300,000 individuals are diagnosed with it each year in the U.S. To develop a consistent method of estimating prostate cancer size, ...

Brachytherapy and proton therapy are radiation therapies, while HIFU and TULSA are focal therapies with distinct mechanisms. Medicare typically covers HIFU but not TULSA, with potential future ...

MRI of the prostate, combined with a blood test, can help determine if a prostate lesion is clinically significant cancer, new research suggests A new meta-analysis by investigators from Brigham and ...

For more than a decade, physicians have debated whether a type of low-risk prostate cancer ought to be called something other than "cancer." Prostate cancer with a Gleason score of 6 does not act like ...

“Most men with early-stage prostate cancer will die with their disease, not from their disease,” Dr Murphy said. Partial gland ablation of MRI-invisible prostate cancer has been controversial. Partial ...